Ranbaxy shareholders gain Rs 1,900 cr in a single day
Investors in Ranbaxy Laboratories got richer by over Rs 1,900 crore in a single day as the scrip surged by a little over 20 per cent on the Bombay Stock Exchange today, a day after the pharma major announced a change of guard at its top management...
By PTI |
MUMBAI: Investors in Ranbaxy Laboratories got richer by over Rs 1,900 crore in a single day as the scrip surged by a little over 20 per cent on the Bombay Stock Exchange today, a day after the pharma major announced a change of guard at its top management level.
The massive addition in the investors' wealth has been cornered by Daiichi Sankyo, which holds 63.92 per cent stake in the domestic drug major as on March 31, 2009.
Daiichi Sankyo's wealth swelled by a whopping Rs 1,229.60 crore in a single trading session.
Shares of Ranbaxy Lab settled higher by 20.73 per cent at Rs 266.70 on BSE. During the trade, the scrip had rallied 24 per cent to touch a high of Rs 273.35.
At the end of trade, Ranbaxy's market capitalisation stood at Rs 11,211.26 crore, an addition of Rs 1,923.66 crore over Rs 9,287.60 crore at the end of Friday's trade.
On the volume front, the scrip remained among the top traded counters with over 2.21 crore shares changing hands.
Ranbaxy chief Malvinder Mohan Singh yesterday resigned as CMD, paving way for the appointment of Atul Sobti as the new Chief Executive Officer and Managing Director for three years. Also Tsutomu Une, non-executive director, has been elected as Chairman of the board of Ranbaxy.
The scrip has jumped two-fold from its 52-week low of Rs 133.15 witnessed on March 12, 2009.
The massive addition in the investors' wealth has been cornered by Daiichi Sankyo, which holds 63.92 per cent stake in the domestic drug major as on March 31, 2009.
Daiichi Sankyo's wealth swelled by a whopping Rs 1,229.60 crore in a single trading session.
Shares of Ranbaxy Lab settled higher by 20.73 per cent at Rs 266.70 on BSE. During the trade, the scrip had rallied 24 per cent to touch a high of Rs 273.35.
At the end of trade, Ranbaxy's market capitalisation stood at Rs 11,211.26 crore, an addition of Rs 1,923.66 crore over Rs 9,287.60 crore at the end of Friday's trade.
On the volume front, the scrip remained among the top traded counters with over 2.21 crore shares changing hands.
ADVERTISEMENT
Ranbaxy chief Malvinder Mohan Singh yesterday resigned as CMD, paving way for the appointment of Atul Sobti as the new Chief Executive Officer and Managing Director for three years. Also Tsutomu Une, non-executive director, has been elected as Chairman of the board of Ranbaxy.
The scrip has jumped two-fold from its 52-week low of Rs 133.15 witnessed on March 12, 2009.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
